Novel EGCG Analog Modulates Host Immune Response to Promote Intracellular Clearance of Staphylococcus Aureus Through Interaction With the 67‐kDa Laminin Receptor
Immunity, Inflammation and Disease · 2026-11 · 14 (11)
DOI: 10.1002/iid3.70606 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 17.11.2026. Verfasst von Riley Grosso und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Southern California, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Catechin, Receptors, Laminin, Staphylococcal Infections, Staphylococcus aureus. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Staphylococcus aureus bacteremia (SAB) is a leading cause of sepsis. Intracellular bacterial survival in liver macrophages contributes to persistent bacteremia. We evaluated the immunometabolic action of EGCG epigallocatechin gallate (EGCG), a green tea polyphenol, and its synthetic analogs (MCC‐2 and MCC‐4) and the putative target, 67‐kDa laminin receptor (67LR). Materials and Methods Murine Kupffer cells (KCs) were infected with live or heat‐killed MRSA and treated with study compounds alone or in combination with vancomycin. Intracellular bacterial clearance was assessed at 0, 10, and 24 h post‐treatment. KCs were challenged with heat‐killed SA when evaluating compound immunometabolic activity: ROS generation using dihydroethidium fluorescence, TNF‐α and IL‐10 production by ELISA, and mitochondrial biogenesis markers (PGC‐1 α, TFAM, mtDNA) by qRT‐PCR, and MitoTracker assays. The role of 67LR mediating immunometabolic action was investigated by receptor disruption and binding studies via computational docking and surface plasmon resonance (SPR).
Results
MCC‐2 enhanced KC‐mediated intracellular MRSA clearance by 1.07 log CFU reduction when combined with vancomycin compared to vancomycin alone. Enhanced clearance was accompanied by up to a 269% increase in ROS generation, a 3.4‐fold increase in the TNF‐α/IL‐10 ratio, and a 25% increase in mitochondrial mass. Receptor disruption and binding studies suggest that MCC‐2 activity is mediated partially via 67LR. MCC‐4 showed similar mitochondrial activating effects as MCC‐2 but was devoid of any antibacterial or immune enhancing activity.
Discussion
MCC‐2 demonstrates promise for further development as an adjunct candidate to antibiotic therapy given its immunometabolic action in enhancing macrophage antimicrobial function while restoring mitochondrial competence through the putative target, 67LR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Southern California, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, Los Angeles, California, USA.
- Molecular and Cellular Biology Program, Department of Biological Sciences, University of Southern California, Los Angeles, California, USA.
- Center of Excellence in NanoBiophysics, University of Southern California, Los Angeles, California, USA.
ORCID-Profile: Riley Grosso, Annie Wong-Beringer
Zitieren
APA
Grosso, R., Ahmed, S. K., Li, S., & Wong-Beringer, A. (2026). Novel EGCG Analog Modulates Host Immune Response to Promote Intracellular Clearance of Staphylococcus Aureus Through Interaction With the 67‐kDa Laminin Receptor. Immunity, Inflammation and Disease, 14(11). https://doi.org/10.1002/iid3.70606
Vancouver
Grosso R, Ahmed SK, Li S, Wong-Beringer A. Novel EGCG Analog Modulates Host Immune Response to Promote Intracellular Clearance of Staphylococcus Aureus Through Interaction With the 67‐kDa Laminin Receptor. Immunity, Inflammation and Disease. 2026;14(11). doi:10.1002/iid3.70606
BibTeX
@article{Grosso2026,
author = {Grosso, Riley and Ahmed, Syed Kaleem and Li, Shuxing and Wong-Beringer, Annie},
title = {Novel EGCG Analog Modulates Host Immune Response to Promote Intracellular Clearance of Staphylococcus Aureus Through Interaction With the 67‐kDa Laminin Receptor},
journal = {Immunity, Inflammation and Disease},
year = {2026},
volume = {14},
number = {11},
doi = {10.1002/iid3.70606}
}
EUVIMED